Stock Earnings

Question 1

What are Cadrenal Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Cadrenal Therapeutics Inc has a total asset of $10, Net loss of $-10

Question 2

What are the key financial ratios for CVKD?

Accepted Answer

Cadrenal Therapeutics Inc's Current ratio is 5, has a Net margin is 0, sales per share of $0.

Question 3

How is Cadrenal Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Cadrenal Therapeutics Inc data is not available.

Question 4

Is Cadrenal Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Cadrenal Therapeutics Inc has a net loss of $-10

Question 5

Does Cadrenal Therapeutics Inc have any liabilities?

Accepted Answer

yes, Cadrenal Therapeutics Inc has liability of 2

Question 6

How many outstanding shares for Cadrenal Therapeutics Inc?

Accepted Answer

Cadrenal Therapeutics Inc has a total outstanding shares of 1.78

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--
Cost of Revenue	--	--	--	--	--
Gross Profit	--	--	--	--	--
Selling, General & Admin	9	6	3	2	--
Research & Development	4	4	4	0	--
Operating Expenses	14	10	7	2	--
Other Non Operating Income (Expenses)	--	--	--	--	--
Pretax Income	-14	-10	-8	-6	--
Income Tax Expense	--	--	--	0	--
Net Income	-14	-10	-8	-6	--
Net Income Growth	100%	25%	33%	--	--
Shares Outstanding (Diluted)	2.04	1.21	0.89	7.89	--
Shares Change (YoY)	85%	36%	-89%	--	--
EPS (Diluted)	-7.03	-8.73	-9.29	-0.85	--
EPS Growth	2%	-6%	993%	--	--
Free Cash Flow	-11	-7	-3	-1	--
Free Cash Flow Per Share	-5.38	-5.73	-3.33	-0.12	--
Gross Margin	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	--
Free Cash Flow Margin	0%	0%	0%	0%	--
EBITDA	-14	-10	-7	-2	--
EBITDA Margin	0%	0%	0%	0%	--
D&A For EBITDA	0	0	0	0	--
EBIT	-14	-10	-7	-2	0
EBIT Margin	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	0%	--

Cadrenal Therapeutics Inc (CVKD) Price